The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 17, 2015

Filed:

Jan. 21, 2011
Applicants:

Luc Berghman, College Station, TX (US);

Walter Bottje, Fayetteville, AR (US);

Billy Hargis, Fayetteville, AR (US);

Sherryll Layton, Rogers, AR (US);

Inventors:

Luc Berghman, College Station, TX (US);

Walter Bottje, Fayetteville, AR (US);

Billy Hargis, Fayetteville, AR (US);

Sherryll Layton, Rogers, AR (US);

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01); A61K 39/385 (2006.01); A61K 39/145 (2006.01); A61K 39/02 (2006.01); A61K 45/00 (2006.01); C12Q 1/68 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 2039/523 (2013.01); A61K 2039/542 (2013.01); A61K 2039/543 (2013.01); A61K 2039/6006 (2013.01); C12N 2760/16034 (2013.01);
Abstract

Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide present on the surface of the vaccine vector. Compositions comprising the vaccine vectors are also provided and include a pharmaceutically acceptable carrier, suitably a carrier for oral or nasal administration. Also provided are methods of enhancing immune responses, in particular antibody immune response and suitably an IgA response, by administering the vaccine vectors or compositions disclosed herein to a subject.


Find Patent Forward Citations

Loading…